ProfileGDS5822 / ILMN_1232025
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 76% 83% 82% 77% 80% 80% 79% 78% 77% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 190.476
GSM1276600PDAC Late Ablation Control 221383
GSM1276601PDAC Late Ablation Control 3236.682
GSM1276602PDAC Late Ablation 199.277
GSM1276603PDAC Late Ablation 2156.580
GSM1276604PDAC Late Ablation 3154.480
GSM1303940PDAC Late Ablation_anti-CTLA4 1117.379
GSM1303941PDAC Late Ablation_anti-CTLA4 2151.478
GSM1303942PDAC Late Ablation_anti-CTLA4 3130.777